Get the Stockscreener App
4.299
0.23%
-0.006
Achieve Life Sciences Inc stock is traded at $4.299, with a volume of 33,626.
It is down -0.23% in the last 24 hours and down -13.76% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$4.305
Open:
$4.25
24h Volume:
33,626
Relative Volume:
0.32
Market Cap:
$147.88M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-1.3823
EPS:
-3.11
Net Cash Flow:
$-24.95M
1W Performance:
-2.16%
1M Performance:
-13.76%
6M Performance:
-16.60%
1Y Performance:
-18.50%
1-Day Range:
$4.19
$4.34
1-Week Range:
$4.12
$4.46
52-Week Range:
$3.03
$5.98
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| ACHV | 4.31 | 147.88M | 0 | -32.94M | -24.95M | -3.11 |
| VRTX | 446.75 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 739.54 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.00 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.15 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.63 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
Achieve Life Sciences Inc Stock (ACHV) Latest News
Drug Discovery Outsourcing Services Market to Achieve a Superb - openPR
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives $14.80 Average Price Target from Analysts - Defense World
HC Wainwright Has Optimistic Outlook of OBIO FY2024 Earnings - Defense World
Achieve Life Sciences (NASDAQ:ACHV) Raised to “Strong-Buy” at RODMAN&RENSHAW - Defense World
FitLife Brands, Inc. Announces Financial Results for Quarter Ended September 30, 2024 - Defense World
Brokerages Set Achieve Life Sciences, Inc. (NASDAQ:ACHV) Target Price at $14.80 - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Upgraded by RODMAN&RENSHAW to "Strong-Buy" Rating - MarketBeat
Achieve Life Sciences stock rated Buy ahead of NDA submission By Investing.com - Investing.com UK
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences - GlobeNewswire
Achieve Life Sciences to Present at Jefferies, Piper Sandler Healthcare Conferences | ACHV Stock News - StockTitan
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Rodman & Renshaw Begins Coverage on Achieve Life Sciences (NASDAQ:ACHV) - MarketBeat
FY2024 Earnings Estimate for ACHV Issued By Zacks Small Cap - Defense World
Research Analysts Set Expectations for ACHV FY2024 Earnings - MarketBeat
ACHV: Commercialization in Focus - Zacks Small Cap Research
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2024 Earnings Call Transcript - Insider Monkey
How to Take Advantage of moves in (ACHV) - Stock Traders Daily
Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com
Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Achieve Life Sciences Reports Q3 2024 Progress - TipRanks
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update - The Manila Times
Parallel Fluidics Secures $7M Seed Round to Accelerate Microfluidic Development for the Next Generation of Life Science Tools - IT News Online
Modular Data Center Market worth $79.49 billion by 2030- Exclusive Report by MarketsandMarkets - The Malaysian Reserve
Vanguard Group Inc's Strategic Acquisition in Achieve Life Scien - GuruFocus.com
JonesTrading Initiates Coverage of Achieve Life Sciences (ACHV) with Buy Recommendation - MSN
Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare - ForexTV.com
Achieve Life Sciences (ACHV) to Release Earnings on Thursday - MarketBeat
MasterControl Honors Excellence at Annual Masters Summit - PR Newswire
Builds Bio+ Announces London/UK Chapter to Boost Transatlantic Life Sciences Collaboration - Business Wire
Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences Industry - Business Wire India
ApiJect receives grant to develop low-cost injection device for LMICs - European Pharmaceutical Manufacturer
Achieve Life Sciences to Announce Third Quarter Financial - GlobeNewswire
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024 - The Manila Times
Supercharging R&D in Life Sciences - Snowflake
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting - The Manila Times
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, - GlobeNewswire
Sanctuary Advisors LLC Invests $171,000 in Legg Mason BW Global Income Opportunities Fund Inc. (NYSE:BWG) - Defense World
Long Term Trading Analysis for (ACHV) - Stock Traders Daily
Co-founders Mulvaney, Brennan return to BenevolentAI as CEO Moeller departs - BioCentury
Achieve Life Sciences appoints new Chief Commercial Officer - Investing.com
Achieve Life Sciences appoints new Chief Commercial Officer By Investing.com - Investing.com UK
Achieve Life Sciences Promotes Jaime Xinos to Chief - GlobeNewswire
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline - GlobeNewswire Inc.
How can you use content to achieve goals beyond the usual scope? - European Pharmaceutical Manufacturer
Automotive Sensors Market Size to Achieve USD 61.7 Billion by 2034 with 5% CAGR, as Sensors Drive Optimal Vehicle Performance: Transparency Market Research Inc. - Yahoo Finance
Automotive Smart Antenna Market Size Set to Achieve USD 8.5 Billion by 2034, Supported by an 8.1% CAGR | Transparency Market Research Inc. - Yahoo Finance
Healthcare IT Outsourcing Market Is Projected To Achieve A Market Value Of ~US$ 94.46 Bn By 2030, Reflectin... - WhaTech
Qunova becomes first to achieve ‘chemical acc - EurekAlert
Renaissance Technologies LLC Sells 11,873 Shares of SR Bancorp, Inc. (NASDAQ:SRBK) - Defense World
Jones Trading maintains $20 target on Achieve Life Sciences stock By Investing.com - Investing.com UK
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Achieve Life Sciences Inc Stock (ACHV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JACOBS CINDY | President & CMO |
Apr 19 '24 |
Option Exercise |
0.00 |
16,250 |
0 |
34,511 |
| Stewart Richard Alistair | Executive Chairman |
Apr 19 '24 |
Option Exercise |
0.00 |
22,500 |
0 |
61,001 |
| Bencich John | CEO |
Apr 19 '24 |
Option Exercise |
0.00 |
25,000 |
0 |
101,724 |
| Stewart Richard Alistair | Executive Chairman |
Mar 04 '24 |
Buy |
4.58 |
10,000 |
45,850 |
38,501 |
| Bencich John | CEO |
Mar 04 '24 |
Buy |
4.58 |
10,000 |
45,850 |
76,724 |
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):